Researchers In Japan Finds Mood Stabilizing Drugs Activate Neural Stem Cells
This article was originally published in PharmAsia News
A research team at the Japan National Institute of Physiologic Sciences announced May 27 that they found anti-depression mood stabilizing drugs can activate and increase neural stem cells. The group hopes the research will lead to the discovery of new treatments for brain damage caused by external injury or disease. Mood stabilizing drugs contain chemicals such as lithium and valproic acid. After three weeks, the number of brain neural stem cells of all the mice who received mood stabilizing drugs increased 1.5 over the control group. Neural stem cells increased 2.4 times in mice given lithium (Click here for more - Japanese language
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.